Pharmafile Logo

Peter Impey

- PMLiVE

HealthUnlocked appoints business development director

Aji Barot joins the online social network for health

- PMLiVE

Hey You! campaign targets over 60s at high risk of stroke

Bayer launches atrial fibrillation awareness drive starring rock and roll

Mereo BioPharma appoints CFO

Richard Jones joins the rare diseases specialist

Bristol-Myers Squibb (BMS) building

NICE backs BMS leukaemia drug Sprycel

Watchdog approves blood cancer therapy for use by NHS in England and Wales

dengue fever mosquito

Dosing of GSK’s malaria vaccine due to start in 2018

WHO sanctions pilot programme in sub-Saharan Africa to begin gathering field data

- PMLiVE

Another late-stage setback tarnishes Gilead’s R&D lustre

Myelofibrosis drug candidate fails to best Incyte/Novartis’ Jakafi in phase III trials

- PMLiVE

The new launch paradigm

The journey from capabilities excellence to effectiveness

- PMLiVE

SGS Life Sciences strengthens medical team

Appoints Dr Katrien Lemmens as medical director

Roche's Perjeta pertuzumab

NICE backs Roche’s Perjeta for routine NHS use

Set to become first new breast cancer drug in nine years after discount agreed

- PMLiVE

Boehringer says Avastin biosimilar on track as Phase III gets underway

Clinical data suggests candidate has same biologic profile as Roche’s cancer drug

- PMLiVE

Ono faces steep price cut for Opdivo in Japan

Japanese regulator proposes 50% cut after drug’s population growth exceeds initial projections

- PMLiVE

DDB Remedy and McCann Health among 2016 Rx Club winners

And McCann Echo takes home the prestigious Carveth's Way Award

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links